SCHEMBL21875372

SCHEMBL21875372

CC1CCCN(c2nc(CCl)cs2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
DNM1L O00429 5/20 0.46
ALDH1A1 P00352 3/20 0.45
TSHR P16473 2/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MAPT P10636 5/20 0.39
TP53 P04637 2/20 0.39
KMT2A Q03164 2/20 0.36
MAP4K4 O95819 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8852641 0.80 SMN1; SMN2 (0.46) DNM1LALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL10136897 0.80 L3MBTL1 (0.49) LMNADNM1LALDH1A1TSHRKDM4E
SCHEMBL20548151 0.79 SMN1; SMN2 (0.49) DNM1LALDH1A1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL7181442 0.79 SMN1; SMN2 (0.45) DNM1LALDH1A1KDM4ENPC1RAB9A
SCHEMBL1436131 0.79 SMN1; SMN2 (0.49) DNM1LALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL2563583 0.75 ALDH1A1 (0.45) LMNADNM1LALDH1A1TSHRKDM4E
SCHEMBL7427898 0.72 LMNA (0.40) LMNAALDH1A1KDM4ENPC1RAB9A
SCHEMBL21875350 0.72 DNM1L (0.75) DNM1L
SCHEMBL13634188 0.72 DNM1L (0.49) LMNADNM1L
SCHEMBL19051356 0.71 SMN1; SMN2 (0.50) LMNAALDH1A1TSHRKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11168080-B2 Dynamin-1-like protein inhibitors MITOBRIDGE, INC. (US) 2021-11-09 US disclosed
US-11168080-B2 Dynamin-1-like protein inhibitors MITOBRIDGE, INC. (US) 2021-11-09 US disclosed
US-20200131172-A1 DYNAMIN-1-LIKE PROTEIN INHIBITORS Astellas Engineered Small Molecules US, Incorporated 2020-04-30 US disclosed
US-20200131172-A1 DYNAMIN-1-LIKE PROTEIN INHIBITORS Astellas Engineered Small Molecules US, Incorporated 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11168080-B2 Dynamin-1-like protein inhibitors DNM1L, DNM1, DNM2 LMNA 2627/4885DNM1L 1/4885ALDH1A1 4737/4885
US-20200131172-A1 DYNAMIN-1-LIKE PROTEIN INHIBITORS DNM1L, DNM1, DNM2 LMNA 2627/4885DNM1L 1/4885ALDH1A1 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.